Your browser doesn't support javascript.
loading
The cost of treating diabetic ketoacidosis in an adolescent population in the UK: a national survey of hospital resource use.
Dhatariya, K K; Parsekar, K; Skedgel, C; Datta, V; Hill, P; Fordham, R.
Afiliación
  • Dhatariya KK; Elsie Bertram Diabetes Centre, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK.
  • Parsekar K; Norwich Medical School, University of East Anglia, Norwich, UK.
  • Skedgel C; Health Economics Consulting, Norwich Medical School, University of East Anglia, Norwich, UK.
  • Datta V; Health Economics Consulting, Norwich Medical School, University of East Anglia, Norwich, UK.
  • Hill P; Diabetes Department, Jenny Lind Children's Hospital, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK.
  • Fordham R; Diabetes Department, Jenny Lind Children's Hospital, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK.
Diabet Med ; 36(8): 982-987, 2019 08.
Article en En | MEDLINE | ID: mdl-30614052
AIMS: Adolescents with Type 1 diabetes commonly experience episodes of ketoacidosis. In 2014, we conducted a nationwide survey on the management of diabetic ketoacidosis in young people. The survey reported how individual adolescents with diabetes were managed. However, the costs of treating diabetic ketoacidosis were not reported. METHODS: Using this mixed population sample of adolescents, we took a 'bottom-up' approach to cost analysis aiming to determine the total expense associated with treating diabetic ketoacidosis. The data were derived using the information from the national UK survey of 71 individuals, collected via questionnaires sent to specialist paediatric diabetes services in England and Wales. RESULTS: Several assumptions had to be made when analysing the data because the initial survey collection tool was not designed with a health economic model in mind. The mean time to resolution of diabetic ketoacidosis was 15.0 h [95% confidence interval (CI) 13.2, 16.8] and the mean total length of stay was 2.4 days (95% CI 1.9, 3.0). Based on data for individuals and using the British Society of Paediatric Endocrinology and Diabetes (BSPED) guidelines, the cost analysis shows that for this cohort, the average cost for an episode of diabetic ketoacidosis was £1387 (95% CI 1120, 1653). Regression analysis showed a significant cost saving of £762 (95% CI 140, 1574; P = 0.04) among those treated using BSPED guidelines. CONCLUSION: We have used a bottom-up approach to calculate the costs of an episode of diabetic ketoacidosis in adolescents. These data suggest that following treatment guidelines can significantly lower the costs for managing episodes of diabetic ketoacidosis.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cetoacidosis Diabética / Diabetes Mellitus Tipo 1 / Hospitalización Tipo de estudio: Guideline / Health_economic_evaluation / Observational_studies / Qualitative_research / Risk_factors_studies Límite: Adolescent / Humans País/Región como asunto: Europa Idioma: En Revista: Diabet Med Asunto de la revista: ENDOCRINOLOGIA Año: 2019 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cetoacidosis Diabética / Diabetes Mellitus Tipo 1 / Hospitalización Tipo de estudio: Guideline / Health_economic_evaluation / Observational_studies / Qualitative_research / Risk_factors_studies Límite: Adolescent / Humans País/Región como asunto: Europa Idioma: En Revista: Diabet Med Asunto de la revista: ENDOCRINOLOGIA Año: 2019 Tipo del documento: Article Pais de publicación: Reino Unido